Appropriate Use Advisory Committee: Summary of affiliations and interests

In accordance with the Health Canada Policy on External Advisory Bodies, all members were asked to disclose affiliations and interests relevant to the mandate of the Appropriate Use Advisory Committee.

Members are expected to review their affiliations and interests against meeting agenda items and advise the Chair and Secretariat if they see a potential cause for concern regarding the integrity and objectivity of their participation. Based on this review, they will decide, if necessary, to limit a member's participation in all or part of the meeting agenda. They will inform the member of this decision.

Summaries are provided for each of the Advisory Committee members based on the following questions.

1. Direct financial interests

1. Do you, your spouse or common-law partner, or dependent family member have any direct financial interests that are of relevance to the mandate of the Advisory Committee, including current employment, investments in companies, partnerships, equity, royalties, joint ventures, trusts, real property, stocks, shares, or bonds?

2. Indirect financial interests

1. Within the past five years, have you, your spouse or common-law partner, or dependent family member received payment for work done or being done, or financial support, from a party that has an interest in the mandate of the Advisory Committee? Include past employment, contracts or consulting, research support, personal education grants, contributions, fellowships, sponsorships, and honoraria for teaching, speaking, or writing engagements.
2. Within the past five years, have you, your spouse or common-law partner, or dependent family member received materials, discounted products, gifts, or other benefits, or attended conferences or meetings where all or part of the travel and accommodation costs were provided by a party that has an interest in the mandate of the Advisory Committee?
3. Within the past five years, have any of the organizations where you, your spouse or common-law partner, or dependent family member are currently employed or participate in internal decision making (for example: as a board member or as an executive or non-executive director) received grants or other funding from a party that has an interest in the mandate of the Advisory Committee?

3. Intellectual interest

1. Within the past five years, have you provided any formal advice or opinion to industry; a Canadian federal, provincial, or municipal government; a foreign government; or a non-government organization on a matter of relevance to the mandate of the Advisory Committee? Include, for example, expert testimony or acting as witness (full or part-time), participation on an advisory body etc.
2. Have you ever made public a statement (e.g. speeches, lobbying) or publicly stated a point of view (including in scientific papers, articles, journals, or other publications, or on other websites) on issues of relevance to the Advisory Committee's mandate?
3. Do you currently have any professional or volunteer affiliations (such as membership in professional/scientific societies, trade associations, or in public interest, or advocacy groups) that may have an interest in the mandate and work of this Advisory Committee?

4. Other

1. Do you, your spouse or common-law partner, or dependent family member have any other affiliations and interests or potential circumstances that might give a well-informed member of the public reasonable apprehension or grounds for concern regarding the integrity and objectivity of your participation in this advisory committee?
2. Are you active on social media on issues relevant to this Advisory Committee?

Summary of affiliations and interests

Name	Summary of Responses
Stephen Samis (Chair)	1a.	2a.	2b.	2c.	3a.	3b.	3c.	4a.	4b.
	Yes	No	Yes	No	Yes	No	Yes	No	No
	Comments
	Attended the Northwinds conference, where accommodation and conference fees were paid by the organizers. Companies in attendance included health and life sciences insurers, pharmaceutical companies and other private and public sector participants. As Deputy Minister of Health and Social Services for the Government of Yukon, was responsible for significant formal advice to the Minister of Health and Social Services, the Premier of Yukon, the Yukon Government Cabinet and the Chief of Staff to the Premier and the Government of Yukon generally. Through consulting work, provided related advice / opinion to: The Canadian Institute for Health Information; The University of Calgary; and Healthcare Excellence Canada Adjunct Faculty appointment, Department of Community Health Sciences, O'Brien Institute for Public Health, Cumming School of Medicine, University of Calgary. Chair, Board of Directors, Imagine Citizen's Network, Alberta
Michael Allan	1a.	2a.	2b.	2c.	3a.	3b.	3c.	4a.	4b.
	No	No	No	No	No	Yes	Yes	No	No
	Comments
	As an academic and an employee of the College of Family Physicians of Canada (CFPC), has written and spoke on multiple different pharmaceuticals (and non-pharmaceuticals interventions) in relation to a long list of conditions and their management in primary care. The CFPC does not have a financial interest in the work of the Advisory Committee, but it plays a role in advocacy for health and family physicians. It is a non-profit. Part of the PEER group (Patients, Experience, Evidence, Research), a primary care evidence team focused on practical application of best evidence in primary care. They are affiliated with CFPC.
Julia Bareham	1a.	2a.	2b.	2c.	3a.	3b.	3c.	4a.	4b.
	No	Yes	No	Yes	Yes	No	Yes	No	No
	Comments
	Current Advisory Committee member for the Drugs and Therapeutics Advisory Committee (DTAC) at Non-Insured Health Benefits (NIHB) under Indigenous Services Canada. Receives an honorarium and reimbursement for any travel expenses. Employed with RxFiles at the University of Saskatchewan. RxFiles receives grants from the Saskatchewan Drug Plan and Extended benefits Brand (through Sask Health). Member of the Pharmacy Association of Saskatchewan as well as the Canadian Society of Hospital Pharmacists. These are both pharmacy advocacy bodies.
Chantal Faucher-Francoeur	1a.	2a.	2b.	2c.	3a.	3b.	3c.	4a.	4b.
	No	No	No	No	No	No	No	No	No
	Comments
	n/a
Sudha Kutty	1a.	2a.	2b.	2c.	3a.	3b.	3c.	4a.	4b.
	No	No	No	No	No	No	No	No	No
	Comments
	n/a
Wendy Levinson	1a.	2a.	2b.	2c.	3a.	3b.	3c.	4a.	4b.
	Yes	No	No	No	No	Yes	No	No	No
	Comments
	Chair of Choosing Wisely Canada—through Unity Health, University of Toronto. Includes in presentations about Choosing Wisely Canada the importance of appropriate prescribing and not using medications that are not necessary or are harmful to patients.
Stan Marchuk	1a.	2a.	2b.	2c.	3a.	3b.	3c.	4a.	4b.
	No	No	No	No	No	No	Yes	No	No
	Comments
	n/a
Connie Newman	1a.	2a.	2b.	2c.	3a.	3b.	3c.	4a.	4b.
	No	No	No	Yes	Yes	Yes	Yes	No	No
	Comments
	Executive Director for Manitoba Association of Senior Communities (MASC). MASC received a grant from Sanoufi Pasteur for promotion of vaccines, and a grant from Psyer for promotion of vaccines. Met with MB Provincial Government– Public Health (2021) on the need to educate older adults on the need for vaccines. MASC works closely with Canadian Medication Appropriateness and Deprescribing Network (CADeN) on medication harm Member of the CADeN and a member of Public Health Agency of Canada's Age Friendly Reference Group
Danielle Paes	1a.	2a.	2b.	2c.	3a.	3b.	3c.	4a.	4b.
	Yes	No	No	Yes	Yes	Yes	Yes	No	No
	Comments
	Currently employed as the Chief Pharmacist Officer at the Canadian Pharmacists Association (CPhA). Witness on behalf of CPhA presenting to Parliament of Canada House of Commons Standing Committee on Health in April and June, 2022 Public Health Association of Canada – Canadian Immunization Conference Organizing Committee 2023 - Present Coalition for Action for Health Workers 2022 - present Canadian Medical Association HHR Steering Committee 2022- present Heart & Stroke Heart Failure Advisory Committee 2021- present Canadian Medication Appropriateness and Deprescribing Network (CADeN) Health Care Provider Committee 2022 – present As primary spokesperson for CPhA, has spoken to media on a variety of issues related to pharmacy and health care in Canada.
Dawn Richards	1a.	2a.	2b.	2c.	3a.	3b.	3c.	4a.	4b.
	No	Yes	Yes	Yes	Yes	Yes	Yes	No	No
	Comments
	Owns, Five02 Labs, Inc (started in 2017). Has participated in advisory boards in a variety of one-off capacities where Five02 Labs has been paid for time to present on life experiences with rheumatoid arthritis or to attend on behalf of the Canadian Arthritis Patient Alliance. Lilly Canada (2019) – compensated to participate on an advisory board and in a public panel Canadian Arthritis Patient Alliance (CAPA) – Company has received an honorarium for operational work contributed to including preparing any patient input submissions (e.g. to CADTH, Health Canada, etc.), and managing projects Travel and one night accommodation for a Lilly Canada advisory board presentation was covered (January 2020) to Montreal. Spoke at this meeting about arthritis patient organizations in Canada and the work they do. Volunteer Vice President of the Canadian Arthritis Patient Alliance (CAPA) and CAPA is supported mainly through independent grants from pharmaceutical companies. Each year the total amount varies from a variety of companies (such as GSK, AbbVie, Janssen, Pfizer, UCB, etc). Member of the Biologics And Biosimilars Massive Open Online Course (MOOC) Advisory Committee of Ontario Health since 2021.
Ambreen Sayani	1a.	2a.	2b.	2c.	3a.	3b.	3c.	4a.	4b.
	No	No	No	No	No	No	Yes	No	No
	Comments
	Scientific lead for Equity-Mobilizing Partnerships in Community (EMPaCT).
Jim Silvius	1a.	2a.	2b.	2c.	3a.	3b.	3c.	4a.	4b.
	Yes	No	No	No	Yes	Yes	Yes	No	No
	Comments
	Senior Medical Director for Alberta Health Services (AHS) with responsibility for the Continuing Care Sector at a provincial level. Executive Director of the Canadian Medication Appropriateness and Deprescribing Network (CADeN), a non-remunerated position and has never benefitted financially from my association with the organization. Chair of the Canadian Drug Expert Committee (CADTH) which is a remunerated position. The role of the committee is specific to making recommendations for provincial, territorial and some Federal programs around pharmaceutical products for coverage under their Formularies. As a founding member of CADeN, co-led with Dr. Justin Turner the development of the National Medication Appropriateness Strategy which are published on the CADeN website and used in consultations on a national approach with many others on this Committee. Membership in the Canadian Geriatric Society (CGS).
Cara Tannenbaum	1a.	2a.	2b.	2c.	3a.	3b.	3c.	4a.	4b.
	No	No	No	No	Yes	Yes	No	Yes	No
	Comments
	Employed as Departmental Science Advisor to Health Canada since October 2019, participant in the Health Canada SAC-Health Products for Women since 2019. 2017-2020 Founder and Past Scientific Director of the Canadian Deprescribing Network: https://www.deprescribingnetwork.ca/ Author(s): Tannenbaum C, Farrell B, Shaw J, Morgan S, Trimble J, Currie J, Turner J, Rochon P, Silvius J. (2017). Title: An ecological approach to reduce the use of potentially inappropriate medications in Canada: the Canadian Deprescribing Network. Journal: Canadian Journal on Aging, 36(1), 97-107. Doi: 10.1017/S0714980816000702 2021 Panelist for annual CADTH meeting symposium, Nov 2021: "Uncertain Times, Imperfect Evidence, and the Imperative to Act.